KPV 10mg

KPV is a synthetic tripeptide reproducing the last three amino acids of α-melanocyte-stimulating hormone (α-MSH): lysine-proline-valine. The molecule emerged from research in the 1990s and 2000s investigating which fragment of α-MSH is responsible for its anti-inflammatory effects, separate from its pigmentation-related signaling. KPV has been studied extensively in models of gut barrier function, inflammatory bowel models, and skin inflammation; the appeal of a 3-residue active fragment is straightforward — it is short enough to synthesize cleanly and stable enough for in-vivo work. This guide explains what KPV is, the published research context, and how each batch is independently verified.

KPV has the amino-acid sequence Lys-Pro-Val — three residues, the absolute minimum for a 'peptide' designation. The molecular weight is approximately 342.4 g/mol with the empirical formula C16H30N4O4. It is supplied as a lyophilized white powder for laboratory reconstitution. In the parent α-MSH peptide, these three residues sit at the C-terminus (positions 11–13 of the 13-amino-acid hormone); the KPV fragment retains a portion of the parent's anti-inflammatory pharmacology while shedding the pigmentation-related signaling associated with the central core of α-MSH.

KPV is sold strictly for laboratory and research use. It is not approved by the FDA or any other regulatory body for human or veterinary use, and nothing in this guide constitutes guidance for human administration.

Published research on KPV is concentrated in two areas. The first is gut research — studies have examined effects on epithelial-barrier integrity, on inflammation markers in colitis models, and on interaction with cell-surface transporters that import tripeptides into intestinal cells. The second is dermal-inflammation research, where KPV has been studied for effects on keratinocyte cytokine release and dendritic-cell activation. The molecular pharmacology is debated; some studies report melanocortin-receptor-dependent effects, others report intracellular signaling that bypasses cell-surface receptors entirely after PEPT1-mediated import. Researchers should evaluate primary sources directly.

Every batch of MHS Longevity KPV is submitted to an independent third-party laboratory before release. Tripeptides are technically the simplest peptides to synthesize cleanly, but their small size means that any impurity represents a meaningful mass fraction of the supplied material — quality verification therefore still matters:

Lyophilized KPV should be stored at -20°C or below for extended stability, though tripeptides are generally more thermally robust than longer sequences and tolerate brief deviations better than 30+ residue molecules. Reconstituted solutions are typically held at 2–8°C and used within the documented stability window. The short length and lack of cysteine, methionine, or tryptophan residues mean KPV has fewer oxidation-sensitive groups than many longer peptides — but standard aseptic technique and avoidance of repeated freeze–thaw cycles still apply.